暂无推荐供应商。我要出现这里
化源商城直购
IC50: 80 nM (Androgen receptor), 22 nM (CYP17A1 enzyme)[1]
[1]. Oksala R, et al. Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1. J Steroid Biochem Mol Biol. 2018 Feb 10. pii: S0960-0760(18)30078-5.